Company Filing History:
1 out of 13 
1 out of 1 Years Active: 2014-2016
Title: Helen Schenk: Innovator in Pharmaceutical Science
Introduction
Helen Schenk is a notable inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in improving the bioavailability of pharmaceutical substances. With a total of 2 patents, her work focuses on methods that enhance the effectiveness of medications.
Latest Patents
Helen Schenk's latest patents include a method for producing prodrugs from amidoxime and N-hydroxyguanidine carboxylic acid esters. This invention relates to a method for improving the bioavailability of pharmaceutical substances, allowing them to permeate the blood-brain barrier. The pharmaceutical substances involved have amidine, guanidine, N-hydroxyamidine (amidoxime), or N-hydroxyguanidine functions. Additionally, she has developed amino acid derivatives used as pharmaceutical substances, which also aim to enhance bioavailability and facilitate the passage through the blood-brain barrier.
Career Highlights
Throughout her career, Helen has worked with various companies, including Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG and Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG. Her innovative approaches have positioned her as a key figure in her field.
Collaborations
Helen has collaborated with notable coworkers such as Bernd Clement and Christiane Wolter-Reeh. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Helen Schenk's contributions to pharmaceutical science through her innovative patents demonstrate her commitment to improving medication efficacy. Her work continues to influence the field and enhance the lives of many.